Ampio Pharm Financials

Ampio Pharm Stock Summary

Ampio Pharm competes with AN2 Therapeutics, Monte Rosa, Candel Therapeutics, Synlogic, and AC Immune. Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.

Ampio Pharm Key Financial Ratios

There are many critical financial ratios that Ampio Pharm's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ampio Pharm reports annually and quarterly.

Ampio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ampio Pharm's current stock value. Our valuation model uses many indicators to compare Ampio Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ampio Pharm competition to find correlations between indicators driving Ampio Pharm's intrinsic value. More Info.Ampio Pharm is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ampio Pharm's earnings, one of the primary drivers of an investment's value.

Ampio Pharm Market Pulse

Along with financial statement analysis, the daily predictive indicators of Ampio Pharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ampio Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ampio Pharm based on widely used predictive technical indicators. In general, we focus on analyzing Ampio Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ampio Pharm's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.